|
Aurobindo Pharma Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
69411.60 Cr.
|
P/BV
|
2.13
|
Book Value (Rs.)
|
562.21
|
|
52 Week High/Low (Rs.)
|
1356/1010
|
FV/ML
|
1/1
|
P/E(X)
|
19.91
|
|
Bookclosure
|
08/08/2025
|
EPS (Rs.)
|
60.02
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 5066.29 | 4379.99 | 2612.50 | 3372.74 | 7343.59 |
| | | | | | |
| Net CashFlow From Operating Activities | 3924.62 | 2434.52 | 2386.75 | 5016.48 | 3328.92 |
| Net Cash Used In Investing Activities | -1875.80 | -4255.95 | -3977.75 | -3211.56 | 598.69 |
| Net Cash Used From Financing Activities | 119.78 | 800.42 | 1814.41 | -2969.27 | -1364.81 |
| Foreign Exchange Gains / Losses | 9.10 | 14.17 | -0.06 | 0.20 | -2.12 |
| Adjustments On Amalgamation / Merger / Demerger And Others | 0.66 | 0.00 | 6.41 | -3.25 | 22.41 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | 2178.36 | -1006.84 | 229.76 | -1167.40 | 2583.09 |
| Cash And Cash Equivalents Begin of Year | 3385.43 | 4392.27 | 4162.51 | 5329.91 | 2746.82 |
| Cash And Cash Equivalents End Of Year | 5563.79 | 3385.43 | 4392.27 | 4162.51 | 5329.91 |
